Finished
Evaluation of the Safety, Effectiveness & Usability of the XACT Robotic System for Image Guided Percutaneous Procedures
NCT03008603 · Xact Robotics Ltd. · Updated 22 Sept 2021
- What is being tested
- XACT Robotic System
- For
- CT-guided Minimally Invasive Procedures e.g., Biopsies
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 60 people. The full rules are on the registry page.
- Where
- United States, Israel (2 sites)
- When
- Starts or started 4 Sept 2018, ends 16 Feb 2021. Registered 2 Jan 2017.
- Results
- None posted yet.
In the researchers' words
This is a prospective, single-arm study is to evaluate the safety, effectiveness and usability of the XACT device. Subjects undergoing CT-guided, minimally invasive percutaneous procedures in the interventional radiology suite, e.g., core biopsy, will participate in the summary. Clinical accuracy will be the primary efficacy endpoint. Usability and safety will also be evaluated.
Sites
- Lahey Hospital & Medical CenterBurlington, Massachusetts, United States
- Hadassah Medical CenterJerusalem, Israel